155 related articles for article (PubMed ID: 31207445)
1. Glucosylated liposomes as drug delivery systems of usnic acid to address bacterial infections.
Francolini I; Giansanti L; Piozzi A; Altieri B; Mauceri A; Mancini G
Colloids Surf B Biointerfaces; 2019 Sep; 181():632-638. PubMed ID: 31207445
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Physicochemical and Antimicrobial Properties of Liposomes Loaded with (+)-Usnic Acid.
Battista S; Bellio P; Celenza G; Galantini L; Franceschini I; Mancini G; Giansanti L
Chempluschem; 2020 May; 85(5):1014-1021. PubMed ID: 32421257
[TBL] [Abstract][Full Text] [Related]
3. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces.
Francolini I; Norris P; Piozzi A; Donelli G; Stoodley P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4360-5. PubMed ID: 15504865
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol loaded in cationic glucosylated liposomes to treat Staphylococcus epidermidis infections.
Pagano L; Gkartziou F; Aiello S; Simonis B; Ceccacci F; Sennato S; Ciogli A; Mourtas S; Spiliopoulou I; Antimisiaris SG; Bombelli C; Mancini G
Chem Phys Lipids; 2022 Mar; 243():105174. PubMed ID: 35038451
[TBL] [Abstract][Full Text] [Related]
5. Release behavior and antibiofilm activity of usnic acid-loaded carboxylated poly(L-lactide) microparticles.
Martinelli A; Bakry A; D'Ilario L; Francolini I; Piozzi A; Taresco V
Eur J Pharm Biopharm; 2014 Oct; 88(2):415-23. PubMed ID: 24929210
[TBL] [Abstract][Full Text] [Related]
6. Mevalonolactone: an inhibitor of Staphylococcus epidermidis adherence and biofilm formation.
Scopel M; Abraham WR; Antunes AL; Henriques AT; Macedo AJ
Med Chem; 2014 May; 10(3):246-51. PubMed ID: 24111986
[TBL] [Abstract][Full Text] [Related]
7. The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm.
Moghadas-Sharif N; Fazly Bazzaz BS; Khameneh B; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2015 Mar; 41(3):445-50. PubMed ID: 24405445
[TBL] [Abstract][Full Text] [Related]
8. Structurally Related Liposomes Containing
Battista S; Bellio P; Fagnani L; Allegritti E; Nazzicone L; Galantini L; Celenza G; Giansanti L
Mol Pharm; 2022 Mar; 19(3):788-797. PubMed ID: 35170971
[TBL] [Abstract][Full Text] [Related]
9. Discovery of quinoline small molecules with potent dispersal activity against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a scaffold hopping strategy.
Abouelhassan Y; Garrison AT; Burch GM; Wong W; Norwood VM; Huigens RW
Bioorg Med Chem Lett; 2014 Nov; 24(21):5076-80. PubMed ID: 25264073
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of Ag and Cu NPs by secondary metabolites of usnic acid and thymol with biological macromolecules aggregation and antibacterial activities against multi drug resistant (MDR) bacteria.
Alavi M; Karimi N
Int J Biol Macromol; 2019 May; 128():893-901. PubMed ID: 30708006
[TBL] [Abstract][Full Text] [Related]
11. Use of liposomes to deliver bactericides to bacterial biofilms.
Jones MN
Methods Enzymol; 2005; 391():211-28. PubMed ID: 15721384
[TBL] [Abstract][Full Text] [Related]
12. Assessment of free fatty acids and cholesteryl esters delivered in liposomes as novel class of antibiotic.
Cheung Lam AH; Sandoval N; Wadhwa R; Gilkes J; Do TQ; Ernst W; Chiang SM; Kosina S; Howard Xu H; Fujii G; Porter E
BMC Res Notes; 2016 Jul; 9():337. PubMed ID: 27391402
[TBL] [Abstract][Full Text] [Related]
13. Usnic Acid Activity on Oxidative and Nitrosative Stress of Azole-Resistant Candida albicans Biofilm.
Peralta MA; da Silva MA; Ortega MG; Cabrera JL; Paraje MG
Planta Med; 2017 Feb; 83(3-04):326-333. PubMed ID: 27648556
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients.
Pompilio A; Pomponio S; Di Vincenzo V; Crocetta V; Nicoletti M; Piovano M; Garbarino JA; Di Bonaventura G
Future Microbiol; 2013 Feb; 8(2):281-92. PubMed ID: 23374132
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial and Efflux Inhibitor Activity of Usnic Acid Against Mycobacterium abscessus.
Ramis IB; Vianna JS; Reis AJ; von Groll A; Ramos DF; Viveiros M; da Silva PEA
Planta Med; 2018 Nov; 84(17):1265-1270. PubMed ID: 29913527
[TBL] [Abstract][Full Text] [Related]
17. Usnic Acid: Potential Role in Management of Wound Infections.
Francolini I; Piozzi A; Donelli G
Adv Exp Med Biol; 2019; 1214():31-41. PubMed ID: 30151647
[TBL] [Abstract][Full Text] [Related]
18. Water soluble usnic acid-polyacrylamide complexes with enhanced antimicrobial activity against Staphylococcus epidermidis.
Francolini I; Taresco V; Crisante F; Martinelli A; D'Ilario L; Piozzi A
Int J Mol Sci; 2013 Apr; 14(4):7356-69. PubMed ID: 23549269
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial efficacy of rifampin loaded solid lipid nanoparticles against Staphylococcus epidermidis biofilm.
Fazly Bazzaz BS; Khameneh B; Zarei H; Golmohammadzadeh S
Microb Pathog; 2016 Apr; 93():137-44. PubMed ID: 26853754
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus.
Pompilio A; Riviello A; Crocetta V; Di Giuseppe F; Pomponio S; Sulpizio M; Di Ilio C; Angelucci S; Barone L; Di Giulio A; Di Bonaventura G
Future Microbiol; 2016 Oct; 11():1315-1338. PubMed ID: 27633726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
